Australian clinical practice guidelines for the diagnosis and management of <scp>B</scp>arrett's esophagus and early esophageal adenocarcinoma
-
- David C Whiteman
- QIMR Berghofer Medical Research Institute Brisbane Queensland Australia
-
- Mark Appleyard
- Royal Brisbane and Women's Hospital Brisbane Queensland Australia
-
- Farzan F Bahin
- Westmead Hospital Sydney New South Wales Australia
-
- Yuri V Bobryshev
- University of New South Wales Sydney New South Wales Australia
-
- Michael J Bourke
- Westmead Hospital Sydney New South Wales Australia
-
- Ian Brown
- Envoi Pathology Brisbane Queensland Australia
-
- Adrian Chung
- Flinders Medical Centre Adelaide South Australia Australia
-
- Andrew Clouston
- Envoi Pathology Brisbane Queensland Australia
-
- Emma Dickins
- Cancer Council Australia Sydney New South Wales Australia
-
- Jon Emery
- University of Melbourne Melbourne Victoria Australia
-
- Guy D Eslick
- University of Sydney Sydney New South Wales Australia
-
- Louisa G Gordon
- Griffith University Brisbane Queensland Australia
-
- Florian Grimpen
- Royal Brisbane and Women's Hospital Brisbane Queensland Australia
-
- Geoff Hebbard
- Royal Melbourne Hospital Melbourne Victoria Australia
-
- Laura Holliday
- Cancer Council Australia Sydney New South Wales Australia
-
- Luke F Hourigan
- Princess Alexandra Hospital University of Queensland Brisbane Queensland Australia
-
- Bradley J Kendall
- QIMR Berghofer Medical Research Institute Brisbane Queensland Australia
-
- Eric YT Lee
- Westmead Hospital Sydney New South Wales Australia
-
- Angelique Levert‐Mignon
- St Vincent's Centre for Applied Medical Research Sydney New South Wales Australia
-
- Reginald V Lord
- St Vincent's Centre for Applied Medical Research Sydney New South Wales Australia
-
- Sarah J Lord
- St Vincent's Centre for Applied Medical Research Sydney New South Wales Australia
-
- Derek Maule
- Cancer Council New South Wales Sydney New South Wales Australia
-
- Alan Moss
- University of Melbourne Melbourne Victoria Australia
-
- Ian Norton
- Royal North Shore Hospital Sydney New South Wales Australia
-
- Ian Olver
- Cancer Council Australia Sydney New South Wales Australia
-
- Darren Pavey
- Bankstown and Concord Hospitals Sydney New South Wales Australia
-
- Spiro Raftopoulos
- Sir Charles Gairdner Hospital Perth Western Australia Australia
-
- Shan Rajendra
- Bankstown‐Lidcombe Hospital Sydney New South Wales Australia
-
- Mark Schoeman
- Royal Adelaide Hospital Adelaide South Australia Australia
-
- Rajvinder Singh
- University of Adelaide Adelaide South Australia Australia
-
- Freddy Sitas
- University of New South Wales Sydney New South Wales Australia
-
- B Mark Smithers
- Princess Alexandra Hospital University of Queensland Brisbane Queensland Australia
-
- Andrew C Taylor
- St Vincent's Hospital Melbourne Victoria Australia
-
- Melissa L Thomas
- St Vincent's Centre for Applied Medical Research Sydney New South Wales Australia
-
- Iain Thomson
- Princess Alexandra Hospital University of Queensland Brisbane Queensland Australia
-
- Henry To
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
-
- Jutta von Dincklage
- Cancer Council Australia Sydney New South Wales Australia
-
- Christine Vuletich
- Cancer Council Australia Sydney New South Wales Australia
-
- David I Watson
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
-
- Ian F Yusoff
- Sir Charles Gairdner Hospital Perth Western Australia Australia
説明
<jats:title>Abstract</jats:title><jats:p><jats:styled-content style="fixed-case">B</jats:styled-content>arrett's esophagus (<jats:styled-content style="fixed-case">BE</jats:styled-content>), a common condition, is the only known precursor to esophageal adenocarcinoma (<jats:styled-content style="fixed-case">EAC</jats:styled-content>). There is uncertainty about the best way to manage <jats:styled-content style="fixed-case">BE</jats:styled-content> as most people with <jats:styled-content style="fixed-case">BE</jats:styled-content> never develop <jats:styled-content style="fixed-case">EAC</jats:styled-content> and most patients diagnosed with <jats:styled-content style="fixed-case">EAC</jats:styled-content> have no preceding diagnosis of <jats:styled-content style="fixed-case">BE</jats:styled-content>. Moreover, there have been recent advances in knowledge and practice about the management of <jats:styled-content style="fixed-case">BE</jats:styled-content> and early <jats:styled-content style="fixed-case">EAC</jats:styled-content>. To aid clinical decision making in this rapidly moving field, <jats:styled-content style="fixed-case">C</jats:styled-content>ancer <jats:styled-content style="fixed-case">C</jats:styled-content>ouncil <jats:styled-content style="fixed-case">A</jats:styled-content>ustralia convened an expert working party to identify pertinent clinical questions. The questions covered a wide range of topics including endoscopic and histological definitions of <jats:styled-content style="fixed-case">BE</jats:styled-content> and early <jats:styled-content style="fixed-case">EAC</jats:styled-content>; prevalence, incidence, natural history, and risk factors for <jats:styled-content style="fixed-case">BE</jats:styled-content>; and methods for managing <jats:styled-content style="fixed-case">BE</jats:styled-content> and early <jats:styled-content style="fixed-case">EAC</jats:styled-content>. The latter considered modification of lifestyle factors; screening and surveillance strategies; and medical, endoscopic, and surgical interventions. To answer each question, the working party systematically reviewed the literature and developed a set of recommendations through consensus. Evidence underpinning each recommendation was rated according to quality and applicability.</jats:p>
収録刊行物
-
- Journal of Gastroenterology and Hepatology
-
Journal of Gastroenterology and Hepatology 30 (5), 804-820, 2015-04-10
Wiley